|Present||Deputy Director and Chief Scientific Officer, Baptist Health South Florida ‐ Miami Cancer Institute|
Professional Service and Affiliations
|1995||Fellowship Program - Medical Oncology/Drug Developm, University of Texas Health Science Center San Antonio||1992||Fellowship Program - Medical Oncology, Roswell Park Cancer Institute (New York)||1990||Fellowship Program - Medical Oncology, University of Minnesota||1989||Residency Program - Internal Medicine, SUNY Health Sciences Center at Brooklyn|
|1985||Doctor of Medicine, M.D., UNIVERSIDAD NACIONAL PEDRO HENRIQUEZ URENA (UNPHU)|
Book Chapters (1)
Research Works (239)
Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid ...
Cancer Chemotherapy and Pharmacology (2015)
Paclitaxel and carboplatin upregulate thymidine phosphorylase and thus may provide synergistic antitumor activity in combination with capecitabine (CTX). We, therefore, ...